Occidental Petroleum Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Occidental Petroleum Corporation trades at $57.8 (market cap $56.20B), while Zimmer Biomet Holdings Inc trades at $88.69 (market cap $17.20B). The key difference: Occidental Petroleum Corporation is far larger — about 3.3× Zimmer Biomet Holdings Inc's market cap, and Occidental Petroleum Corporation pays the higher dividend (1.84%). Which is the better fit depends on your goals.
| OXY | ZBH | |
|---|---|---|
Market Cap | $56.20B | $17.20B |
Sector | Energy | Health |
52-Week High | $66.24 | $107.71 |
52-Week Low | $38.92 | $79.58 |
Enterprise Value | $77.28B | $24.25B |
Dividend Yield | 1.84% | 1.08% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Trailing returns across standard periods
Latest headlines on both assets
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →